Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis
Clinical trial NCT02503657 · COMPLETED
Trial details
- NCT number
- NCT02503657
- Sponsor
- MediciNova
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-09
- Primary completion
- 2020-12-07
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.